There is currently no vaccine against schistosomiasis. With few Schistosoma vaccine candidates in clinical trials, unexplored antigens from the vulnerable schistosomulum should be considered as possible vaccine candidates. In addition, we suggest developing synthetic vesicles as a new delivery vehicle and adjuvant for immunoprophylactic schistosomula vaccine candidates.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.pt.2017.07.007 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!